Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves

Journal of Heart Valve Disease

Volumn 21, Issue 5, 2012, Pages 670-678

  Dijkman, Petra E ^a   Driessen Mol, Anita ^a   De Heer, Linda M ^b   Kluin, Jolanda ^b   Van Herwerden, Lex A ^b   Odermatt, Berhard ^c   Baaijens, Frank P T ^a   Hoerstrup, Simon P ^a,c  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; POLY 4 HYDROXYBUTYRATE; POLYGLYCOLIC ACID; POLYMER; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; EXPLANT; HEART VALVE REPLACEMENT; IN VITRO STUDY; IN VIVO STUDY; NITINOL STENT; NONHUMAN; PRIORITY JOURNAL; SELF EXPANDING STENT; TISSUE ENGINEERED HEART VALVE; TISSUE ENGINEERING; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; BIOPROSTHESIS; COMPARATIVE STUDY; HEART VALVE PROSTHESIS; MINIMALLY INVASIVE SURGERY; PATHOLOGY; PULMONARY VALVE; SHEEP;

ANIMALS; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; PULMONARY VALVE; SHEEP; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TISSUE ENGINEERING;

EID: 84871882967     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rosengart TK, Feldman T, Borger MA, et al. Percutaneous and minimally invasive valve procedures: A scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008;117:1750-1767
2. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: Step by step. Ann Thorac Surg 2009;87:276-283
3. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation 2007;116:I240-I245
4. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006;114:591-596
5. Fernandes SM, Khairy P, Sanders SP, Colan SD. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol 2007;49:2211-2214
6. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-1900
7. Hoerstrup SP, Kadner A, Melnitchouk S, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106:I143-I150
8. Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102:III44-III49
9. Mol A, Rutten MC, Driessen NJ, et al. Autologous human tissue-engineered heart valves: Prospects for systemic application. Circulation 2006;114:I152-I158
10. Flanagan TC, Sachweh JS, Frese J, et al. In vivo remodeling and structural characterization of fibrin- based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 2009;15:2965-2976
11. Gottlieb D, Kunal T, Emani S, et al. In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg 2010;139:723-731
12. Sutherland FW, Perry TE, Yu Y, et al. From stem cells to viable autologous semilunar heart valve. Circulation 2005;111:2783-2791
13. Schmidt D, Dijkman PE, Driessen-Mol A, et al. Minimally-invasive implantation of living tissue engineered heart valves: A comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 2010;56:510-520
14. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009;30:1482-1491
15. Ceonzo K, Gaynor A, Shaffer L, Kojima K, Vacanti CA, Stahl GL. Polyglycolic acid-induced inflammation: Role of hydrolysis and resulting complement activation. Tissue Eng 2006;12:301-308
16. Hoerstrup SP, Cummings M, I, Lachat M, et al. Functional growth in tissue-engineered living, vascular grafts: Follow-up at 100 weeks in a large animal model. Circulation 2006;114:I159-I166